Rich Pharmaceuticals Reaches Agreement with Geopulse Exploration, Inc. (Cannco Brands)
October 07, 2019 07:47 ET
|
Rich Pharmaceuticals
LOS ANGELES, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) has agreed to be partially acquired by Geopulse Exploration, Inc. (OTC PINK: GPLS),...
Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients
April 10, 2018 07:00 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA , April 10, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma
March 14, 2018 09:45 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
Rich Pharmaceuticals' Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy
March 06, 2018 09:45 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA, March 06, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), is a Biopharmaceutical Company focused on developing and commercializing innovative therapies in...
UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials
December 05, 2017 12:35 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...
Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials
December 05, 2017 10:35 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...